Drug intelligence / Profile preview

[18F]F-RESCA-RB14

Development stage
Phase 2
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

[18F]F-RESCA-RB14 is a radiopharmaceutical compound designed for positron emission tomography (PET) imaging. It utilizes the fluorine-18 isotope, which is well-suited for PET due to its favorable half-life and imaging properties. The RESCA chelator enables efficient and mild radiolabeling of peptides, proteins, or biologics with fluorine-18 via the Al[18F]F method. This approach allows rapid, one-step synthesis under Good Manufacturing Practices (GMP), making it suitable for clinical applications where high image resolution and centralized production are advantageous. The specific biological target or indication of RB14 is not detailed in available sources; however, compounds labeled with [18F] using RESCA are typically developed as molecular imaging agents to visualize specific targets in oncology or other disease areas[8].

Other names
[18F]F-RB14
02

Targets

ERBB2 (Erb-b2 receptor tyrosine kinase 2)

Beyond the preview

Go deeper on [18F]F-RESCA-RB14.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on [18F]F-RESCA-RB14.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call